Phase 3 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are suspected of having or have been diagnosed with a tumour near the area where the pancreas meets the small intestine (called a periampullary tumour), and for whom a specific type of pancreatic surgery (called a Whipple procedure or pylorus-preserving pancreaticoduodenectomy) is planned.
- People whose pancreas tissue is soft and whose main pancreatic duct is narrower than 3mm, which puts them at higher risk of a specific complication after surgery — this is confirmed both before and during the operation.
- People who have given written agreement to take part after being fully informed about the trial.
Who may not be able to join:
- People who are planned to have additional surgical procedures performed at the same time as the pancreatic surgery.
- People who have been diagnosed with a different primary cancer (a cancer originating somewhere other than the area being treated).
- People who have previously received an organ or tissue transplant.
- People known to be living with HIV.
- People who test positive for hepatitis C antibodies, hepatitis B surface antigens, or hepatitis B core antibodies.
- People who have diabetes that is managed with insulin.
- People who have had a known allergic reaction to any of the medications used in this trial, their ingredients, or medications with a similar chemical makeup.
- People who are currently taking part in another clinical trial, or who have done so within the four weeks before joining this trial.
- People whose health conditions or substance use may prevent them from fully understanding what participation in the trial involves.
- People who are pregnant or breastfeeding.
- People of childbearing age, unless they meet at least one of the following conditions: have gone through natural menopause (no periods for 12 months, or 6 months with confirmed hormone levels); have had both ovaries surgically removed at least 6 weeks prior; are consistently using a contraceptive method with a failure rate of less than 1% per year; are abstaining from sex; or have a partner who has had a vasectomy.
- People where there is concern they may not be able to follow the trial procedures as required.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Barbara Ludwig, Prof. Dr., Department of internal Medicine III
Phone: +49 458
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Duration between surgery and time "fit for adjuvant treatment" (postoperative day X)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.